MAYDEL GRINAN: Open Payments
NPI 1497466999 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,018 in 51 payments from 16 companies in 2025. Trend: 2023 $446 · 2024 $762 · 2025 $2,018
Food & beverage: $2,010Education: $8
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 8 | $617 |
| ABBVIE INC. | 11 | $302 |
| GENZYME CORPORATION | 4 | $209 |
| Ardelyx, Inc. | 4 | $194 |
| Amgen Inc. | 3 | $173 |
| Regeneron Healthcare Solutions, Inc. | 4 | $111 |
| Ferring Pharmaceuticals Inc. | 4 | $92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $88 |
| Medtronic, Inc. | 2 | $50 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
Products named: REZDIFFRA, DUPIXENT, IBSRELA, CREON, UPLIZNA, REBYOTA, XIFAXAN, INTERSTIM.
Industry payments across FL — which companies pay providers there.
